Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta Physiologica Sinica ; (6): 439-450, 2023.
Artigo em Chinês | WPRIM | ID: wpr-981019

RESUMO

Lipid metabolism is a complex physiological process, which is closely related to nutrient regulation, hormone balance and endocrine function. It involves the interactions of multiple factors and signal transduction pathways. Lipid metabolism disorder is one of the main mechanisms to induce a variety of diseases, such as obesity, diabetes, non-alcoholic fatty liver disease, hepatitis, hepatocellular carcinoma and their complications. At present, more and more studies have found that the "dynamic modification" of N6-adenylate methylation (m6A) on RNA represents a new "post-transcriptional" regulation mode. m6A methylation modification can occur in mRNA, tRNA, ncRNA, etc. Its abnormal modification can regulate gene expression changes and alternative splicing events. Many latest references have reported that m6A RNA modification is involved in the epigenetic regulation of lipid metabolism disorder. Based on the major diseases induced by lipid metabolism disorders, we reviewed the regulatory roles of m6A modification in the occurrence and development of those diseases. These overall findings inform further in-depth investigations of the underlying molecular mechanisms regarding the pathogenesis of lipid metabolism disorders from the perspective of epigenetics, and provide reference for health prevention, molecular diagnosis and treatment of related diseases.


Assuntos
Humanos , Metilação , Epigênese Genética , Metabolismo dos Lipídeos/genética , Transtornos do Metabolismo dos Lipídeos/genética , Neoplasias Hepáticas , RNA
2.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 545-548, 2015.
Artigo em Chinês | WPRIM | ID: wpr-297388

RESUMO

<p><b>OBJECTIVE</b>To explore the effect of Qingfei Huoxue Recipe (QHR) combined azithromycin in treatment of intractable pediatric mycoplasma pneumonia.</p><p><b>METHODS</b>Totally 124 intractable pediatric mycoplasma pneumonia patients at our hospital were recruited in this study, and randomly assigned to the treatment group and the control group, 62 in each group. Patients in the control group took azithromycin, while those in the treatment group additionally took QHR. All patients received omnibearing systematic nursing. Therapeutic efficacy, clinical indices (such as disappearance time of cough and rales, recovery time of body temperature) , and the incidence of adverse reactions were observed.</p><p><b>RESULTS</b>After treatment the total effective rate was 91.94% (57/62 cases) in the treatment group and 77. 42% (48/62 cases) in the control group with statistical difference (P < 0.05). Compared with the control group, disappearance time of cough and rales, recovery time of body temperature were obviously shortened in the treatment group with statistical difference (P < 0.01). There was statistical difference in the incidence of adverse reactions between the two groups [3.23% (2/62 cases) vs 38.71% (24/62 cases) , P < 0.01].</p><p><b>CONCLUSION</b>In clinical treatment for intractable pediatric mycoplasma pneumonia, Chinese medicine combined Western medicine plus scientific and systematic nursing showed more obvious advantages with significant efficacy, which was worth spreading.</p>


Assuntos
Criança , Humanos , Azitromicina , Pesquisa Biomédica , Tosse , Medicamentos de Ervas Chinesas , Usos Terapêuticos , Medicina Tradicional do Leste Asiático , Fitoterapia , Pneumonia por Mycoplasma , Tratamento Farmacológico
3.
Chinese Journal of Contemporary Pediatrics ; (12): 851-855, 2014.
Artigo em Chinês | WPRIM | ID: wpr-254185

RESUMO

<p><b>OBJECTIVE</b>To study the effect of uncoupling protein 2 (UCP2)-siRNA on the inflammatory response of rat cardiomyocytes (H9C2) induced by septic serum and to investigate the possible role of UCP2 in the development of septic cardiomyopathy.</p><p><b>METHODS</b>Serum samples were separately collected from normal rats and septic rats. Cultured rat cardiac cells (H9C2) were randomly divided into blank control, normal serum, 10% septic serum, UCP2-siRNA+10% septic serum and negative siRNA+10% septic serum groups. Stimulation with 10% septic serum was performed for 12 hours in relevant groups. The mRNA expression of tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) was measured by RT-PCR. The expression of phosphorylated p38 mitogen-activated protein kinase (p-p38 MAPK) and nuclear factor-kappa B (NF-κB) was measured by Western blot.</p><p><b>RESULTS</b>The expression levels of p-p38 and NF-κB in the UCP2-siRNA+10% septic serum group were significantly higher than in the 10% septic serum group (P<0.05). The UCP2-siRNA+10% septic serum group had a significantly higher TNF-α mRNA expression than the 10% septic serum group (P<0.01), but IL-1β mRNA expression showed no significant difference between the two groups.</p><p><b>CONCLUSIONS</b>UCP2 plays a regulatory role in the activation of p38 MAPK and NF-κB and the expression of downstream inflammatory mediators in H9C2 cells stimulated with septic serum.</p>


Assuntos
Animais , Masculino , Ratos , Cardiomiopatias , Células Cultivadas , Inflamação , Interleucina-1beta , Genética , Canais Iônicos , Genética , Fisiologia , Proteínas Mitocondriais , Genética , Fisiologia , Miócitos Cardíacos , Metabolismo , NF-kappa B , Metabolismo , RNA Interferente Pequeno , Genética , Ratos Sprague-Dawley , Sepse , Sangue , Fator de Necrose Tumoral alfa , Genética , Proteína Desacopladora 2 , Proteínas Quinases p38 Ativadas por Mitógeno , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA